Eli Lilly to buy gene therapy developer Adverum in about $262 million deal - Reuters

Reuters | Oct. 24, 2025, 10:12 a.m. | Original
Eli Lilly to buy gene therapy developer Adverum in about $262 million deal Reuters
News by Acceswire on TradingView, 2025-10-24 - TradingView Europe's new space merger explores the FOMO frontier - Reuters